The Clinicians Speak, page-905

Another paper highlighting the benefits of using BTM, this time in extensive burns in a large number of patients.

I particularly liked the following statement

The NovoSorbR Biodegradable Temporizing Matrix (BTM), developed by PolyNovo Biomaterials Pty Ltd. in Port Melbourne, Australia, stands out as an innovative dermal substitute.

Findings were

• Take rates of BTM and STSG were high.
• No need to stuff around with initial temporary coverage with allograft, said to be the prevalent approach to treating large burns. Drawbacks of allografts are heightened risk of infection, more surgeries, frequent dressing changes and limited availability. Results for BTM take and subsequent skin graft take were shown to be improved when allograft wasn’t used first.
• Overall, reduced resource requirements.
• Fast and easy application.
• Shorter operation times.
• Intervals between dressing changes for BTM longer than for allografts.
• Provides better opportunity for recovery from intensive care issues and early mobilization.
• Provides better opportunity for early physical therapy.
• Provides flexibility around timing of subsequent skin grafting.
• Can be safely used with the Meek technique of wound coverage.